Home World News Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis... World News Superior EFS and OS in Patients with Nonmetastatic Osteosarcoma and Unfavourable Prognosis when Adjuvant Mifamurtide is Combined with High-Dose Ifosfamide By Ogkologos - August 28, 2025 326 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ISG/OS-2 and GEIS-33 studies Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Neoadjuvant Docetaxel, Oxaliplatin, and S-1, as Part of Perioperative Chemotherapy, Prolongs... August 19, 2024 Adjuvant Pembrolizumab Continues to Demonstrate Benefit in DFS and OS Among... September 3, 2026 Laser-Based Device Detects and Kills Melanoma Cells in the Blood, Study... July 25, 2019 “After a fire and a pandemic, it felt amazing to finish... November 1, 2021 Load more HOT NEWS How Adolescent and Young Adult Cancer Survivors Can Cope With the... Perioperative Durvalumab Continues to Show Clinical Benefit in Patients with Resectable... No Clinically Meaningful Difference in Survival Between Nivolumab Plus Ipilimumab and... Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer...
